In the present study, we found that the transcription activities of CXXC4, NKD1 and PRICKLE1 were all significantly upregulated in MM cells following treatment with GSK126, which may help explanation of the inhibition of Wnt/β-catenin pathway. The gene discussed is NKD1; the disease is Miyoshi myopathy.